AmacaThera, a clinical-stage biotechnology company specializing in drug delivery, announced it has signed a binding ...

Cantata Health Solutions, a leading provider of healthcare technology solutions for behavioral health and human services providers, announces Arize MAT, a new Medication-Assisted Treatment (MAT) ...

AI medical scribes can reduce documentation burdens, improve provider productivity and enhance the overall patient experience ...

New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent MELBOURNE, Australia, April 29, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: ...

Part 2a is designed to confirm the primary dose-of-interest with a target enrollment of approximately 30 patients at each of two dose levels: 400mg QD 5:2 and 300mg QD 5:2 (intermittent daily dosing ...

Customers Delivered Value with Process Orchestration and AI Capabilities on the Appian Platform LONDON, April 29, 2025 /PRNewswire/ -- Appian (Nasdaq: APPN) today announced the 2025 Appian ...

Q1 2025 Earnings Call Transcript April 30, 2025 Spok Holdings, Inc. beats earnings expectations. Reported EPS is $0.25, ...

"The strong global launch of YORVIPATH positions 2025 to be an inflection point for Ascendis with growing revenue and a path ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

Roper Technologies, Inc. ( NASDAQ: ROP) Q1 2025 Earnings Conference Call April 28, 2025 8:00 AM ET Zack Moxcey - VP of IR Neil Hunn - President and CEO Jason Conley - EVP and CFO ...

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced that analyses of the initial Phase 3 program of ampreloxetine (Studies 169 and 170) will be ...